Celgene Revenue 2006-2018 | CELG

Current and historical revenue for Celgene (CELG) from 2006 to 2018. The sum of all revenue fields included for a company's operating activities. The current revenue for Celgene as of March 31, 2018 is .
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.002B $13.003B
Celgene Corporation is a global biopharmaceutical company engaged in the discovery, development and commercialization of innovative therapies for the treatment of cancer and immune-inflammatory related diseases. Their portfolio of commercial products include REVLIMID, VIDAZA, THALOMID, POMALYST/IMNOVID, ABRAXANE, OTEZLA, ISTODAX and IDHIFA. The drug candidates in their pipeline are at various stages of preclinical and clinical development. These candidates include their IMiDs compounds, which are a proprietary class of compounds that have certain immunomodulatory and other biologically important properties in addition to their leading oral anti-inflammatory agents and cellular therapies. They believe their commercial stage products and the depth of their product pipeline, provide the catalysts for future growth.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $127.577B 14.95
Gilead Sciences (GILD) United States $100.276B 10.00
Biogen (BIIB) United States $75.648B 15.82
Vertex Pharmaceuticals (VRTX) United States $46.157B 150.94
Illumina (ILMN) United States $45.170B 63.75
Regeneron Pharmaceuticals (REGN) United States $39.415B 23.40
Alexion Pharmaceuticals (ALXN) United States $30.182B 25.12
BioMarin Pharmaceutical (BMRN) United States $18.147B 0.00
Incyte (INCY) United States $14.916B 0.00
Seattle Genetics (SGEN) United States $10.764B 0.00
Alnylam Pharmaceuticals (ALNY) United States $10.592B 0.00
Bluebird Bio (BLUE) United States $8.999B 0.00
BeiGene (BGNE) Cayman Islands $8.874B 0.00
Sarepta Therapeutics (SRPT) United States $8.869B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.516B 68.69
QIAGEN (QGEN) Netherlands $8.376B 28.01
Exact Sciences (EXAS) United States $8.135B 0.00
Alkermes (ALKS) Ireland $6.980B 0.00
Exelixis (EXEL) United States $6.332B 25.70
Bio-Techne Corp (TECH) United States $5.718B 39.22
Integra LifeSciences Holdings (IART) United States $5.531B 29.69
Galapagos (GLPG) Belgium $5.232B 0.00
Ligand Pharmaceuticals (LGND) United States $4.830B 64.78
Immunomedics (IMMU) United States $4.299B 0.00
Ultragenyx Pharmaceutical (RARE) United States $4.215B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $4.149B 0.00
Array BioPharma (ARRY) United States $3.558B 0.00
China Biologic Products (CBPO) China $3.349B 22.12
Spark Therapeutics (ONCE) United States $3.191B 0.00
Myriad Genetics (MYGN) United States $2.993B 36.29
Ascendis Pharma (ASND) Denmark $2.980B 0.00
ARGENX SE-ADR (ARGX) Netherlands $2.978B 0.00
Amicus Therapeutics (FOLD) United States $2.970B 0.00
Medicines (MDCO) United States $2.927B 0.00
Horizon Pharma Public (HZNP) Ireland $2.845B 17.41
Intercept Pharmaceuticals (ICPT) United States $2.831B 0.00
Blueprint Medicines (BPMC) United States $2.795B 0.00
CRISPR THERAPTC (CRSP) Switzerland $2.762B 0.00
Emergent Biosolutions (EBS) United States $2.727B 34.86
Halozyme Therapeutics (HALO) United States $2.521B 38.91
REGENXBIO (RGNX) United States $2.515B 58.33
Akcea Therapeutics (AKCA) United States $2.496B 0.00
Clovis Oncology (CLVS) United States $2.440B 0.00
Momenta Pharmaceuticals (MNTA) United States $2.281B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.194B 0.00
Global Blood Therapeutics (GBT) United States $2.179B 0.00
Arena Pharmaceuticals (ARNA) United States $2.160B 0.00
Acceleron Pharma (XLRN) United States $2.129B 0.00
Repligen (RGEN) United States $2.094B 66.56
MyoKardia (MYOK) United States $2.009B 0.00
Puma Biotechnology (PBYI) United States $1.989B 0.00
Genomic Health (GHDX) United States $1.966B 347.38
Insmed (INSM) United States $1.947B 0.00
Cambrex (CBM) United States $1.857B 17.08
AnaptysBio (ANAB) United States $1.788B 0.00
Atara Biotherapeutics (ATRA) United States $1.751B 0.00
Aimmune Therapeutics (AIMT) United States $1.686B 0.00
Editas Medicine (EDIT) United States $1.673B 0.00
IMMURON LTD (IMRN) Australia $1.571B 0.00
G1 THERAPEUTICS (GTHX) United States $1.560B 0.00
Solid Biosciences (SLDB) United States $1.558B 0.00
Sangamo Therapeutics (SGMO) United States $1.533B 0.00
Audentes Therapeutics (BOLD) United States $1.470B 0.00
Mirati Therapeutics (MRTX) United States $1.460B 0.00
BIOHAVEN PHARM (BHVN) United States $1.438B 0.00
Innoviva (INVA) United States $1.437B 10.53
Deciphera Pharmaceuticals (DCPH) United States $1.422B 0.00
Lexicon Pharmaceuticals (LXRX) United States $1.375B 0.00
Acorda Therapeutics (ACOR) United States $1.351B 0.00
Intellia Therapeutics (NTLA) United States $1.336B 0.00
Denali Therapeutics (DNLI) United States $1.322B 0.00
Myovant Sciences (MYOV) United Kingdom $1.312B 0.00
UniQure (QURE) Netherlands $1.293B 0.00
Lion Biotechnologies (IOVA) United States $1.282B 0.00
Cellectis (CLLS) France $1.273B 0.00
Retrophin (RTRX) United States $1.262B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.255B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.219B 0.00
Athenex (ATNX) United States $1.197B 0.00
Reata Pharmaceuticals (RETA) United States $1.182B 0.00
WAVE Life Sciences (WVE) Singapore $1.118B 0.00
NeoGenomics (NEO) United States $1.113B 230.17
Intra-Cellular Therapies (ITCI) United States $1.109B 0.00
Coherus BioSciences (CHRS) United States $1.095B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.079B 0.00
Revance Therapeutics (RVNC) United States $1.059B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.045B 0.00
DBV Technologies (DBVT) France $1.037B 0.00
Apellis Pharmaceuticals (APLS) United States $1.027B 0.00
Dynavax Technologies (DVAX) United States $0.975B 0.00
CytomX Therapeutics (CTMX) United States $0.960B 0.00
Epizyme (EPZM) United States $0.942B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.880B 0.00
AUTOLUS THERAPT (AUTL) United Kingdom $0.877B 0.00
Amarin (AMRN) Ireland $0.836B 0.00
ANI Pharmaceuticals (ANIP) United States $0.836B 17.12
InflaRx (IFRX) Germany $0.819B 0.00
Heska (HSKA) United States $0.803B 61.50
Inotek Pharmaceuticals (RCKT) United States $0.787B 0.00
AVROBIO INC (AVRO) United States $0.785B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.776B 0.00
EIDOS THERAPEUT (EIDX) United States $0.775B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.764B 0.00
Sorrento Therapeutics (SRNE) United States $0.762B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.749B 0.00
AC Immune SA (ACIU) Switzerland $0.676B 0.00
APTINYX INC (APTX) United States $0.676B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.666B 0.00
Kura Oncology (KURA) United States $0.664B 0.00
Abeona Therapeutics (ABEO) United States $0.660B 0.00
UROGEN PHARMA (URGN) Israel $0.660B 0.00
Cara Therapeutics (CARA) United States $0.648B 0.00
UNITY Biotechnology (UBX) $0.635B 0.00
Arbutus Biopharma (ABUS) Canada $0.623B 0.00
Geron (GERN) United States $0.621B 0.00
Mesoblast (MESO) Australia $0.613B 0.00
Five Prime Therapeutics (FPRX) United States $0.607B 0.00
Viking Therapeutics (VKTX) United States $0.607B 0.00
Tigenix (TIG) Belgium $0.605B 0.00
Prothena (PRTA) Ireland $0.588B 0.00
Fate Therapeutics (FATE) United States $0.583B 0.00
Senesco Technologies (ELOX) United States $0.582B 0.00
ObsEva SA (OBSV) Switzerland $0.580B 0.00
BeyondSpring (BYSI) United States $0.561B 0.00
Merus (MRUS) Netherlands $0.554B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.554B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.539B 0.00
Aduro Biotech (ADRO) United States $0.535B 0.00
Novavax (NVAX) United States $0.531B 0.00
Anika Therapeutics (ANIK) United States $0.512B 20.30
Arcus Biosciences (RCUS) United States $0.509B 0.00
Stemline Therapeutics (STML) United States $0.487B 0.00
MAGENTA THERAPT (MGTA) United States $0.482B 0.00
Cytokineticsorporated (CYTK) United States $0.480B 0.00
Zealand Pharma (ZEAL) Denmark $0.477B 0.00
Verastem (VSTM) United States $0.462B 0.00
Zymeworks (ZYME) Canada $0.457B 0.00
Evelo Biosciences (EVLO) United States $0.445B 0.00
Sinovac Biotech (SVA) China $0.439B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.427B 0.00
Unum Therapeutics (UMRX) United States $0.417B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.409B 0.00
Syros Pharmaceuticals (SYRS) United States $0.406B 0.00
Albireo Pharma (ALBO) United States $0.393B 0.00
Inovio Pharmaceuticals (INO) United States $0.390B 0.00
PDL BioPharma (PDLI) United States $0.386B 3.94
MiMedx (MDXG) United States $0.379B 16.24
Mersana Therapeutics (MRSN) United States $0.377B 0.00
Scholar Rock Holding (SRRK) United States $0.373B 0.00
MediciNova (MNOV) United States $0.369B 0.00
Vericel (VCEL) United States $0.367B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.357B 0.00
Kindred Biosciences (KIN) United States $0.353B 0.00
Cellular Biomedicine (CBMG) United States $0.349B 0.00
GTx (GTXI) United States $0.348B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.338B 0.00
RA PHARMCTL INC (RARX) United States $0.337B 0.00
Vital Therapies (VTL) United States $0.335B 0.00
Clearside Biomedical (CLSD) United States $0.331B 0.00
Seres Therapeutics (MCRB) United States $0.324B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.323B 0.00
Adverum Biotechnologies (ADVM) United States $0.308B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.306B 0.00
KEZAR LIFE SCI (KZR) United States $0.305B 0.00
BioTime (BTX) United States $0.305B 0.00
Kala Pharmaceuticals (KALA) United States $0.303B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.294B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.292B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.288B 0.00
Celyad SA (CYAD) Belgium $0.285B 0.00
Selecta Biosciences (SELB) United States $0.284B 0.00
MEIRAGTX HLDGS (MGTX) United States $0.284B 0.00
Synlogic (SYBX) United States $0.281B 0.00
Athersys (ATHX) United States $0.276B 0.00
Kadmon Holdings (KDMN) United States $0.268B 0.00
OVID THERAPEUTC (OVID) United States $0.263B 0.00
Axovant Sciences (AXON) United Kingdom $0.259B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.258B 0.00
ResTORbio (TORC) United States $0.243B 0.00
Strongbridge Biopharma (SBBP) United States $0.241B 0.00
NantKwest (NK) United States $0.236B 0.00
ChromaDex (CDXC) United States $0.234B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.232B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.228B 0.00
Allena Pharmaceuticals (ALNA) United States $0.227B 0.00
Enzo Biochem (ENZ) United States $0.226B 0.00
MannKind (MNKD) United States $0.225B 0.00
Celcuity (CELC) United States $0.225B 0.00
Cue Biopharma (CUE) United States $0.224B 0.00
Kamada (KMDA) Israel $0.223B 17.90
Cohbar (CWBR) United States $0.223B 0.00
Agenus (AGEN) United States $0.223B 0.00
Signal Genetics (MGEN) United States $0.210B 0.00
ADMA Biologics Inc (ADMA) United States $0.209B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.205B 0.00
Idera Pharmaceuticals (IDRA) United States $0.204B 0.00
XOMA (XOMA) United States $0.202B 15.35
Mustang Bio (MBIO) United States $0.200B 0.00
Palatin Technologies (PTN) United States $0.199B 7.69
Erytech Pharma SA Sponsored ADR (ERYP) $0.194B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.194B 0.00
Krystal Biotech (KRYS) United States $0.190B 0.00
TOCAGEN INC (TOCA) United States $0.182B 0.00
Menlo Therapeutics (MNLO) United States $0.182B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.180B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.178B 0.00
VBI Vaccines (VBIV) United States $0.175B 0.00
BioXcel Therapeutics (BTAI) United States $0.172B 0.00
Compugen (CGEN) Israel $0.172B 0.00
NewLink Genetics (NLNK) United States $0.169B 0.00
Monster Digital (INNT) United States $0.169B 0.00
Protagonist Therapeutics (PTGX) United States $0.166B 0.00
Spero Therapeutics (SPRO) United States $0.164B 0.00
BioDelivery Sciences (BDSI) United States $0.163B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.160B 0.00
Bellerophon Therapeutics (BLPH) United States $0.157B 0.00
XBiotech (XBIT) United States $0.153B 0.00
Organovo Holdings (ONVO) United States $0.152B 0.00
Intec Pharma (NTEC) Israel $0.149B 0.00
Cocrystal Pharma (COCP) United States $0.148B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.142B 0.00
Fortress Biotech (FBIO) United States $0.142B 0.00
Anavex Life Sciences (AVXL) United States $0.139B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.139B 0.00
Pluristem Therapeutics (PSTI) Israel $0.139B 0.00
Catalyst Biosciences (CBIO) United States $0.139B 0.00
Cerecor (CERC) United States $0.137B 21.80
Pfenex (PFNX) United States $0.128B 0.00
Motif Bio Plc (MTFB) United States $0.128B 0.00
Cidara Therapeutics (CDTX) United States $0.126B 0.00
Leap Therapeutics (LPTX) United States $0.121B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.116B 0.00
PSivida (EYPT) United States $0.115B 0.00
Gemphire Therapeutics (GEMP) United States $0.112B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.111B 0.00
Aptose Biosciences (APTO) Canada $0.110B 0.00
Aptevo Therapeutics (APVO) United States $0.107B 0.00
Tapimmune (TPIV) United States $0.104B 0.00
Trevena (TRVN) United States $0.104B 0.00
Proteostasis Therapeutics (PTI) United States $0.101B 0.00
Asterias Biotherapeutics (AST) United States $0.097B 0.00
GENPREX INC (GNPX) United States $0.097B 0.00
Ophthotech (OPHT) United States $0.096B 0.66
Sophiris Bio (SPHS) United States $0.095B 0.00
Eleven Biotherapeutics (SESN) United States $0.094B 0.00
ScPharmaceuticals (SCPH) United States $0.092B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.092B 0.00
Alcobra (ARCT) Israel $0.089B 0.00
Oncolytics Biotech (ONCY) Canada $0.087B 0.00
Orgenesis (ORGS) United States $0.085B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.085B 0.00
Checkpoint Therapeutics (CKPT) United States $0.083B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.082B 0.00
Axsome Therapeutics (AXSM) United States $0.081B 0.00
Alimera Sciences (ALIM) United States $0.080B 0.00
VIVUS (VVUS) United States $0.080B 0.00
Applied Genetic Technologies (AGTC) United States $0.076B 0.00
Advaxis (ADXS) United States $0.075B 0.00
Evogene (EVGN) Israel $0.074B 0.00
Celldex Therapeutics (CLDX) United States $0.073B 0.00
ENTERA BIO LTD (ENTX) Israel $0.072B 0.00
Prima BioMed (IMMP) Australia $0.072B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.071B 0.00
Eyenovia (EYEN) United States $0.069B 0.00
Histogenics (HSGX) United States $0.069B 0.00
OncoSec Medical (ONCS) United States $0.068B 0.00
Novelion Therapeutics (NVLN) Canada $0.067B 0.00
Aileron Therapeutics (ALRN) United States $0.067B 0.00
Vascular Biogenics (VBLT) Israel $0.064B 0.00
Neothetics (EVFM) United States $0.064B 0.00
Protalix BioTherapeutics (PLX) Israel $0.063B 0.00
VolitionRX (VNRX) Singapore $0.061B 0.00
Curis (CRIS) United States $0.056B 0.00
Celsion (CLSN) United States $0.053B 0.00
Caladrius Biosciences (CLBS) United States $0.053B 0.00
Zosano Pharma (ZSAN) United States $0.052B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.048B 0.00
VTv Therapeutics (VTVT) United States $0.048B 0.00
TRACON Pharmaceuticals (TCON) United States $0.047B 0.00
Moleculin Biotech (MBRX) United States $0.046B 0.00
AZURRX BIOPHARM (AZRX) United States $0.045B 0.00
Proteon Therapeutics (PRTO) United States $0.044B 0.00
Arsanis (ASNS) United States $0.043B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.042B 0.00
CytRx (CYTR) United States $0.041B 0.00
AquaBounty Technologies (AQB) United States $0.040B 0.00
Cellect Biotechnology (APOP) Israel $0.040B 0.00
BioPharmX (BPMX) United States $0.038B 0.00
Chiasma (CHMA) United States $0.037B 0.00
OvaScience (OVAS) United States $0.033B 0.00
Edge Therapeutics (EDGE) United States $0.032B 0.00
AEterna Zentaris (AEZS) United States $0.032B 0.00
VistaGen Therapeutics (VTGN) United States $0.031B 0.00
Benitec Biopharma (BNTC) Australia $0.031B 0.00
Oncobiologics (ONS) United States $0.028B 0.00
Synthetic Biologics (SYN) United States $0.027B 0.00
ATyr Pharma (LIFE) United States $0.027B 0.00
Vical (VICL) United States $0.026B 0.00
Cleveland BioLabs (CBLI) United States $0.026B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.025B 0.00
RestorGenex (DFFN) United States $0.024B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.022B 0.00
Genetic Technologies (GENE) Australia $0.021B 0.00
CorMedix Inc (CRMD) United States $0.021B 0.00
Prana Biotechnology (PRAN) Australia $0.020B 0.00
Pulmatrix (PULM) United States $0.020B 0.00
Titan Pharmaceuticals (TTNP) United States $0.019B 0.00
Neuralstem (CUR) United States $0.018B 0.00
Cel-Sci (CVM) United States $0.018B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.018B 0.00
AmpliPhi Biosciences (APHB) United States $0.018B 0.00
Novogen (KZIA) Australia $0.017B 0.00
Flex Pharma (FLKS) United States $0.015B 0.00
Cerulean Pharma (DARE) United States $0.014B 0.00
Hemispherx BioPharma (HEB) United States $0.014B 0.00
Fibrocell Science Inc (FCSC) United States $0.013B 0.00
Therapix Biosciences (TRPX) Israel $0.012B 5.84
Alliqua BioMedical (ALQA) United States $0.011B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.010B 0.00
Tenax Therapeutics (TENX) United States $0.010B 0.00
IBio (IBIO) United States $0.010B 0.00
ImmunoCellular Therapeutics (IMUC) United States $0.010B 0.00
Soligenix (SNGX) United States $0.010B 0.00
Galena Biopharma (SLS) United States $0.010B 0.00
MYOS RENS Technology (MYOS) United States $0.009B 0.00
ARCA Biopharma (ABIO) United States $0.008B 0.00
Immune Pharmaceuticals (IMNP) United States $0.007B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Oragenics (OGEN) United States $0.004B 0.00
TrovaGene (TROV) United States $0.004B 0.00
Aytu Bioscience (AYTU) United States $0.002B 0.00